[HTML][HTML] PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
RD Morgan, AR Clamp, DGR Evans… - Cancer Chemotherapy …, 2018 - Springer
Purpose Poly (ADP-ribose) polymerase inhibitors (PARPi) have changed the management
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
[HTML][HTML] PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
RD Morgan, AR Clamp, DGR Evans… - Cancer …, 2018 - ncbi.nlm.nih.gov
Purpose Poly (ADP-ribose) polymerase inhibitors (PARPi) have changed the management
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
RD Morgan, AR Clamp, DGR Evans… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose Poly (ADP-ribose) polymerase inhibitors (PARPi) have changed the management
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
R Morgan, A Clamp, DG Evans… - Cancer …, 2018 - research.manchester.ac.uk
Purpose Poly (ADP-ribose) polymerase inhibitors (PARPi) have changed the management
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
RD Morgan, AR Clamp, DGR Evans… - Cancer …, 2018 - search.proquest.com
Purpose Poly (ADP-ribose) polymerase inhibitors (PARPi) have changed the management
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer.
RD Morgan, AR Clamp, D Evans, R Edmondson… - 2018 - christie.openrepository.com
Poly (ADP-ribose) polymerase inhibitors (PARPi) have changed the management of high-
grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi was …
grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi was …
[PDF][PDF] PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
RD Morgan, AR Clamp, DGR Evans… - Cancer Chemotherapy …, 2018 - d-nb.info
Purpose Poly (ADP-ribose) polymerase inhibitors (PARPi) have changed the management
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
[引用][C] PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
RD Morgan, AR Clamp, DGR Evans… - Cancer Chemotherapy …, 2018 - cir.nii.ac.jp
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer.
RD Morgan, AR Clamp, DGR Evans… - Cancer …, 2018 - europepmc.org
Purpose Poly (ADP-ribose) polymerase inhibitors (PARPi) have changed the management
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi …
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer.
RD Morgan, AR Clamp, DGR Evans… - Cancer …, 2018 - europepmc.org
PURPOSE: Poly (ADP-ribose) polymerase inhibitors (PARPi) have changed the
management of high-grade serous ovarian cancer (HGSOC). The rationale for the …
management of high-grade serous ovarian cancer (HGSOC). The rationale for the …